
Feature|Videos|May 6, 2025
Patient Services: A Marathon, Not A Sprint
Author(s)Rob Truckenmiller, PharmaCord
Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
Advertisement
In this video, Rob Truckenmiller, CEO of PharmaCord, covers various trends from patient access to specialty medications in the U.S., including trends that are shaping manufacturer strategies. He also defines the difference between enablement and empowerment when it comes to using AI in patient services, and further shares how emerging technologies could influence the future of specialty pharma services.
Key Learning Objectives
- Learn about PharmaCord, its mission, and what distinguishes the organization in a competitive marketplace.
- Understand how patient journeys are evolving in response to market complexity and how manufacturer needs are shifting, and recognize how PharmaCord is building solutions that align with rising expectations.
- Learn about compliant responses regarding PharmaCord's recent press release and strategic growth initiatives, painting a picture of what lies ahead for the organization and the industry at large.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Beyond the Molecule: The New Competitive Battlefield in Oncology
3
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
4
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
5




